The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Novel treatments may help alleviate constipation, IBS in women

WASHINGTON, D.C. (May 21, 2007) -- Three new therapy options, including two novel medications, showed promise in the treatment of irritable bowel syndrome (IBS), according to research presented today at Digestive Disease Week 2007 (DDW). Participants in the studies who received one of the two investigational medications experienced significant relief in constipation, while a third study demonstrated the benefits of hypnotherapy in treating bowel and abdominal complications in children. DDW is the largest international gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.

"With few successful treatment options currently available for IBS sufferers, these studies represent promising progress in the treatment of this and other bowel disorders," said Mara Abreu, M.D., Director, Inflammatory Bowel Disease Center, Associate Professor of Medicine, Mount Sinai School of Medicine.

Lubiprostone Significantly Improves Symptom Relief Rates in Adults with Irritable Bowel Syndrome and Constipation (IBS-C): Data from Two, Twelve-week, Randomized, Placebo-Controlled, Double-blind Trials (Abstract #639f)

Lubiprostone is a novel therapy indicated for treatment of chronic idiopathic constipation in adults. Two twelve-week, independent studies showed patients who received lubiprostone were nearly twice as likely as those who did not receive the treatment to report moderate or significant relief of IBS symptoms. Endpoints included abdominal discomfort, stool consistency, straining and others. Lubiprostone was also well-tolerated, with only one percent of patients experiencing serious adverse events and only 22 percent of patients experiencing related adverse events, compared with 21 percent of patients on placebo.

The studies included more than 1,100 patients, most of whom were female (91.6%) and aged 18-65 years (91.7%). Participants were given either lubip
'"/>

Contact: Aimee Frank
AFrank@gastro.org
301-941-2620
American Gastroenterological Association
21-May-2007


Page: 1 2 3 4

Related medicine news :

1. Novel candidate biomarker for heart failure also strongly predicts risk of death
2. Novel catheter technique successfully patches holes in the heart
3. Novel anti-oxidant and anti-inflammatory agent shows effectiveness on key endpoints in trial
4. Novel Ames Lab composite may replace depleted uranium
5. Novel computed imaging technique uses blurry images to enhance view
6. Novel brain areas associated with the recognition of gender, ethnicity and the identity of faces
7. Novel program enhances dementia caregivers quality of life
8. Novel gene therapy may lead to cure in hemophilia A patients
9. Novel therapy combinations gain ground in treating hepatitis
10. Novel stem cell technology leads to better spinal cord repair
11. Novel virus entry mechanism could lead to new drugs against poxviruses

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Novel treatments may help alleviate constipation IBS women

(Date:11/23/2009)...Animal studies suggest that adding flaxseed oil to... post-menopausal women and women with diabetes, ac...ational Journal of Food Safety, Nutrition and Publ...tional Research Center, in Cairo, Egypt, have stud...uated how flaxseed oil in the diet might delay the...
(Date:11/23/2009)...Since 1996, crop plants genetically modified to pr... insects, yet safe for people, have been planted o...pularity of these Bt crops, named after the bacter...lity to kill some major pests, allowing farmers to...ducing insecticide sprays. , However, since inse...
(Date:11/23/2009)...ding drug to chemo regimen may improve patient out.... 23 (HealthDay News) -- A new combination drug th...nced biliary-tract cancers, researchers say. , ...Cancer Center in Boston found that survival and tu...(Avastin), an angiogenesis inhibitor that has help...
(Date:11/23/2009)...V patients who have it take longer to get sick, st... News) -- Scientists report that a genetic variati... progression in HIV-infected patients. , In f... longer to develop AIDS and die of complications o...that vary across individuals that make a person mo...
(Date:11/23/2009)...,, ,, NASHVILLE,Tenn.,Nov.23/PRNewswire...gedcaremarketintelligence,reportsthatself-insuredm...thCareGrouphaveexperiencedanaggregatehealthcare-co...tthreeyearsofparticipationinahigh-performanceprovi... thecoalitionfoundtheseself-insuredmembercompanies...
Breaking Medicine News(10 mins):Health News:Flaxseed oil and osteoporosis 2Health News:Insect resistance to Bt crops can be predicted, monitored and managed 2Health News:Combo Treatment Beneficial in Biliary-Tract Cancer Study 2Health News:Genetic Variant Slows AIDS Progression 2Health News:Milwaukee Employers See Cost Savings with High-Performance Provider Network 2
(Date:11/23/2009)...BridgePointMedicalannouncedtodaythatitreceivedEuro...ripheralChronicTotalOcclusion(CTO)CrossingSystemco...Stingray®CTORe-EntrySystem.TheBridgePointSyst...dtonavigatehighlydiseasedarteriesinpreparationforb..., TheNationalHeart,LungandBloodInstitute(NHLBI)est...
(Date:11/23/2009)...wire-FirstCall/-- LexiconPharmaceuticals,Inc. (Nas...hase2clinicalstudywith LX1031 inpatientswithnon-co...edatGASTRO2009inLondonthisweek.Resultsfromthestudy...illbepresentedbyDr. PhilipM.Brown ,Lexicon,ssenior...09at2:30pmlocaltimeatthesessionentitled,"Therapeut...
(Date:11/23/2009)...e-FirstCall/--WoundManagementTechnologies,Inc.,(OT...altymedicalproducts,announcedthatithasfileditQ3200...ementbusinessupdatetoillustratethedevelopmentsduri...33.5%to$102,926vs.Q32008salesof$77,084. , Sha....Q32008shareholderequityof$(321,257) , Totala...
Breaking Medicine Technology:BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Obama Signs Tough New Anti Smoking Law 49671 1Obama Signs Tough New Anti Smoking Law 49671 2Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 1Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 2Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 3Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 4Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 5Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 6Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 12732 7Vermont Receives National Award for Physician e Prescribing Thanks to Efforts by Local Healthcare Firm 49668 1Vermont Receives National Award for Physician e Prescribing Thanks to Efforts by Local Healthcare Firm 49668 2
Other News:
...both get high blood pressure and related kidney di...nd just different for men, researchers say.... "Th...got there could be very different," says Dr. Jenni...e Medical College of Georgia Vascular Biology Cent...
... studies presented at this week's Experimental Bio...arch on the nutritional benefits of egg consumptio...role in providing choline, an essential nutrient o...emory development and function. ... Among the find...
...rom low income families have more sleep problems t...ly impacting their health and performance at schoo... the American Academy of Neurologys 59th Annual Me...dy compared the sleeping habits of 64 healthy inne...
...3, 2007 -- Alpharma Inc.(NYSE: ALO), a leading glo...harmaceuticals Division, this week presented posit...stigational abuse-deterrent, extended-release opio...erican Pain Society in Washington, D.C. The data ...
health news:Cause of gender differences in blood pressure, kidney damage under study 2health news:Cause of gender differences in blood pressure, kidney damage under study 3health news:Eggs promote weight loss and help close nutrient consumption gap 2health news:Eggs promote weight loss and help close nutrient consumption gap 3health news:Alpharma presents positive pharmacokinetic study results 2health news:Alpharma presents positive pharmacokinetic study results 3
...- drugs that inhibit cholesterol synthesis -- work...fats and proteins in the blood that have been link...ncludes. Statins' effects on both complex compound...cular risks.......Atherosclerosis is the progressi...
...es the risk of developing cervical tumors, accordi...chool of Public Health and School of Medicine. The...es that found an association between active cigare...a tumor. The concept of the Hopkins study was the ...
...s will have access to intensive leadership trainin...erial College London and the London School for Hyg... Leadership Programme, funded by the Soros Foundat...ho have taken on training and managerial responsib...
...ter variety of organic...potatoes at more affordab......international study today.......Several varieti...onal...palates and cuisine, are adorning supermark...me.......A European study, led by Nafferton Ecolog...
health news:Reduced progression of atherosclerosis tied to statin drugs lowering fats, protein 2health news:Reduced progression of atherosclerosis tied to statin drugs lowering fats, protein 3health news:Secondhand smoke linked to cervical cancer 2health news:New programme will train the next generation of health leaders 2health news:Consumers to benefit from organic potato breakthrough 2